OS benefit with first-line datopotamab deruxtecan in advanced-stage TNBC

Nature Reviews Clinical Oncology 2026

View at publisher

Authors: Diana Romero

DOI: 10.1038/s41571-026-01150-1

Cited by: 1

References: 1

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Lung Cancer Research Studies HER2/EGFR in Cancer Research

References 1